Author: Ravi Shankar

Innovative design will future-proof the EVgo network as vehicle battery capabilities advance while focusing on features to enhance the customer experience

LOS ANGELES, Sept. 29, 2026 (GLOBE NEWSWIRE) — EVgo Inc. (Nasdaq: EVGO) (“EVgo” or the “Company”), one of the nation’s largest public fast charging networks for electric vehicles (EVs), shared a preview of its next-generation charging system, capable of delivering up to 750kW of charging power.

Design, development, and testing for the Company’s new charger are being performed at EVgo’s Innovation Lab in El Segundo, California, with co-development support from longtime partner Delta Electronics. With this architecture, EVgo is one of the only American charging networks to design its own chargers.

“EVgo has served EV drivers for over 15 years, and our investment in our 750kW next-generation architecture future-proofs our network for current and future vehicles,” said Badar Khan, CEO of EVgo. “Charge rates seen on the EVgo network are increasing, up nearly 20% in the last two years. We expect that to continue, and our new architecture will help meet growing demand for high-power charging while delivering an industry-leading customer experience for EV drivers.”

At the heart of EVgo’s design is a focus on the EV driver experience, leveraging learnings from working with 1.8 million customer accounts and analyzing data from over 10 million sessions per year. Features include better cable maneuverability, a touchless payment interface, and advanced hardware and firmware to bolster reliability and streamline the charging experience. Each station will feature NACS connectors as part of EVgo’s overall strategy to double its addressable market by welcoming more NACS drivers to its customer base. This system is expected to charge the fastest charging vehicles in the U.S. market in around 10 minutes.¹

The new chargers will use dynamic power sharing, which is increasingly important as battery technology advances and charge rate variability widens across available vehicle models for consumers. This approach ensures each dispenser delivers the exact output each vehicle needs throughout a charging session, automatically adjusting energy distribution in real time. Drivers won’t have to worry about finding a certain power-level stall because every stall is the right one for their vehicle. Dynamic power sharing also supports grid stability through flexible energy allocation, routing power where it is needed most while smoothing demand spikes.

The final charger design is expected to be unveiled in 2027 as EVgo begins to deploy the new architecture. 

¹ Actual charging time will vary based on vehicle’s charging speed and settings, battery condition, ambient temperature, and initial state of charge. See our FAQs for recommended charging parameters and assumptions. 

About EVgo 

EVgo (NASDAQ: EVGO) is one of the nation’s largest and most highly utilized public fast charging providers. With more than 1,200 fast charging locations across 47 states, EVgo makes charging part of everyday life by partnering with leading businesses including retailers, grocery stores, rideshare operators and autonomous vehicle companies. EVgo is scaling nationwide, strategically deploying high-power chargers, including EVgo Superchargers, across the U.S. At its dedicated Innovation Lab, EVgo is developing its next-generation chargers, performing extensive interoperability testing and collaborating with leading automakers and industry partners to advance the EV charging industry and deliver a seamless charging experience.

Forward-Looking Statements 

This press release contains forward-looking statements that are subject to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to: EVgo’s plans, projections, and expectations regarding its next-generation chargers; the capabilities and features of such chargers, including cable maneuverability, NACS, and hardware and firmware features and the impact they will have on reliability and customer experience; and the anticipated impact of such chargers on EVgo’s charging network, the expected timing of deployment, and benefits for EVgo’s customers. Forward-looking statements are based on EVgo’s management’s current assumptions, expectations, and beliefs and are not guarantees of future performance. These statements are subject to a number of risks, uncertainties, and assumptions, including those described under the heading “Risk Factors” and elsewhere in our most recent Quarterly Reports on Form 10-Q and Annual Reports on Form 10-K filed with the Securities and Exchange Commission. In light of these risks, uncertainties, and assumptions, actual results could differ materially and adversely from those anticipated or implied by the forward-looking statements. You should not rely on forward-looking statements as predictors of future results. Any forward-looking statements in this release are based on the limited information currently available to EVgo as of the date hereof, which is subject to change, and EVgo does not undertake any obligation to update these statements, even if new information becomes available in the future.

Contacts    

For Investors:
investors@evgo.com     

For Media:
press@evgo.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/74bb6a65-ae35-489f-8994-de1870f44466

New Guidance Represents an Increase of $55 Million at the Midpoint from the Prior Range of $350 to $370 Million

Strong U.S. Demand for Amtagvi and Proleukin Drives Increased Outlook

PHILADELPHIA, Sept. 29, 2026 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, today raised its full year 2026 total revenue guidance range to $410 to $420 million, driven by strong U.S. demand for Amtagvi® (lifileucel) and Proleukin. The midpoint represents an increase of $55 million, or ~15%, over the previous guidance range of $350 to $370 million and implies nearly 60% annual growth in total revenue.

“Our record second quarter and sustained demand for Amtagvi and Proleukin led us to raise our full year 2026 total revenue guidance by $55 million at the midpoint,” said Frederick Vogt, Ph.D., J.D., Interim President and Chief Executive Officer. “Increasing patient demand and our current manufacturing schedule provide strong visibility into our third and fourth quarter revenues. In addition, lifileucel continues to advance across our registrational programs in new solid tumor indications, while continued manufacturing and operating efficiencies accelerate our progress toward profitability.”

Iovance most recently reported record second quarter 2026 total product revenue of $99.3 million, has grown its authorized treatment center (ATC) network to ~100 centers, and remains on track for expansion to at least 110 ATCs by year-end 2026.

Iovance expects to report third quarter 2026 financial results in early November 2026. This update completes the guidance review announced with the Company’s second quarter 2026 results.

About Iovance Biotherapeutics, Inc. 

Iovance Biotherapeutics, Inc. is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. Amtagvi® (lifileucel) is the first FDA-approved, one-time treatment for previously treated advanced melanoma, now approved in three global markets and available at nearly 100 authorized treatment centers (ATCs). The Iovance TIL platform spans registrational trials and next-generation programs in additional solid tumors, including gene-edited and IL-12 tethered TIL therapies, next-generation IL-2, and precision immuno-oncology approaches. As the first and only company to take TIL therapy from concept to a broadly accessible commercial treatment, Iovance operates as an end-to-end cell therapy company, anchored by fully owned, centralized U.S.-based manufacturing that is scaled to serve thousands of cancer patients worldwide each year. Headquartered in Pennsylvania with offices and laboratories in California and Florida, Iovance serves patients at ATCs and clinical sites across almost the entire U.S. and in many countries around the world. For more information, please visit www.iovance.com.

Amtagvi® and its accompanying design marks, Proleukin^®, Iovance^®, and IovanceCares™ are trademarks and registered trademarks of Iovance Biotherapeutics, Inc. or its subsidiaries. All other trademarks and registered trademarks are the property of their respective owners.

Information on Iovance’s broad, industry-leading patent portfolio is available on the Intellectual Property page on www.iovance.com.

Forward-Looking Statements

Certain matters discussed in this press release are “forward-looking statements” of Iovance Biotherapeutics, Inc. (hereinafter referred to as the “Company,” “we,” “us,” or “our”) within the meaning of the Private Securities Litigation Reform Act of 1995 (the “PSLRA”). Without limiting the foregoing, we may, in some cases, use terms such as “predicts,” “believes,” “potential,” “continue,” “estimates,” “anticipates,” “expects,” “plans,” “intends,” “forecast,” “guidance,” “outlook,” “may,” “can,” “could,” “might,” “will,” “should,” or other words that convey uncertainty of future events or outcomes and are intended to identify forward-looking statements. Forward-looking statements are based on assumptions and assessments made in light of management’s experience and perception of historical trends, current conditions, expected future developments, and other factors believed to be appropriate. Forward-looking statements in this press release are made as of the date of this press release, and we undertake no duty to update or revise any such statements, whether as a result of new information, future events, or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, many of which are outside of our control, that may cause actual results, levels of activity, performance, achievements, and developments to be materially different from those expressed in or implied by these forward-looking statements. Important factors that could cause actual results, developments, and business decisions to differ materially from forward-looking statements are described in the sections titled “Risk Factors” in our filings with the U.S. Securities and Exchange Commission, including our most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, and include, but are not limited to, the following substantial known and unknown risks and uncertainties inherent in our business: the risks related to our ability to successfully commercialize our products; the acceptance by the market of our products and product candidates, if approved, and their potential pricing and/or reimbursement by payors, and whether such acceptance is sufficient to support continued commercialization or development of our products or product candidates; the risk regarding our ability to manufacture our therapies at our iCTC facility, including the risk that our ability to increase manufacturing capacity at our facility may adversely affect our commercial launch; the risks related to our ability to obtain, maintain and enforce patent and other intellectual property protection for our products and product candidates; the risk that the successful development or commercialization of our products may not generate sufficient revenue from product sales, and we may not become profitable in the near term, or at all; the risks related to the timing of and our ability to successfully develop, submit, obtain, or maintain regulatory authority approval of our product candidates; whether clinical trial results from our pivotal studies and cohorts, and meetings with regulatory authorities, may support registrational studies and subsequent approvals by regulatory authorities, including the risk that any of our planned registrational trials may not support approval; preliminary and interim clinical results, which may include efficacy and safety results, from ongoing clinical trials or cohorts may not be reflected in the final analyses of our ongoing clinical trials or subgroups within these trials or in other prior trials or cohorts; the risk that we may be required to conduct additional clinical trials or modify ongoing or future clinical trials based on feedback from regulatory authorities; the risk that our interpretation of the results of our clinical trials or communications with regulatory authorities may differ from the interpretation of such results or communications by such regulatory authorities; the risk that clinical data from ongoing clinical trials of Amtagvi will not continue or be repeated in ongoing or planned clinical trials or may not support regulatory approval or renewal of authorization; the risk that unanticipated expenses may decrease our estimated cash balances and forecasts and increase our estimated capital requirements; the risk that we may not be able to recognize revenue for our products; the risk that Proleukin revenues, and other factors such as the number of ATCs, may not serve as a leading indicator for Amtagvi revenues; the risks regarding our anticipated operating and financial performance, including our financial guidance and projections; the effects of global and domestic geopolitical factors or public health events; and other factors, including general economic conditions and regulatory developments, not within our control. Any financial guidance provided in this press release assumes the following: no material change in our ability to manufacture our products; no material change in payor coverage; no material change in revenue recognition policies; no new business development transactions not completed as of the period covered by this press release; and no material fluctuation in exchange rates.

CONTACTS 

Investors
IR@iovance.com
650-260-7120 ext. 150

Media
PR@iovance.com 
650-260-7120 ext. 150

• Jurassic Battery Energy Storage System is Alberta’s largest battery energy storage facility, delivering 80 MW / 160 MWh of grid-balancing capacity
• Northland’s second storage project was delivered ahead of schedule and under budget with zero lost-time incidents
• 15-year offtake agreement covering 100% of capacity provides long-term contracted cash flows

TORONTO, Sept. 29, 2026 (GLOBE NEWSWIRE) — Northland Power Inc. (“Northland” or the “Company”) (TSX: NPI) today announced that its 80 MW / 160 MWh Jurassic Battery Energy Storage System (BESS) has achieved commercial operations, bringing Alberta’s largest battery storage facility online and marking another milestone in Northland’s successful project delivery.

The Jurassic BESS facility was delivered ahead of schedule and under budget. The project was constructed with zero lost-time incidents across nearly 75,000 hours worked. The project is supported by a 15-year offtake agreement covering 100% of its capacity, providing long-term contracted cash flows.

“Achieving commercial operations at Jurassic BESS demonstrates Northland’s ability to consistently deliver energy infrastructure safely, efficiently, and as planned,” said Christine Healy, President and Chief Executive Officer of Northland Power. “Jurassic BESS highlights our exceptional project execution and multi-technology capabilities and operations across electricity generation and storage.”

ABOUT NORTHLAND POWER

Northland Power is a Canadian-headquartered global power producer delivering the electricity the world needs through offshore wind, onshore renewables, battery storage, and natural gas-fired generation. With offices in seven countries, Northland owns, in whole or in part, 3.6 GW of gross operating generating capacity, 2.4 GW under construction, and an approximately 8 GW development pipeline, reflecting nearly four decades of experience delivering large-scale energy infrastructure. 

Publicly traded since 1997, Northland’s Common Shares, and Series 1 and Series 2 Preferred Shares trade on the Toronto Stock Exchange under the symbols NPI, NPI.PR.A and NPI.PR.B, respectively. 

For further information, please contact:

Alison Holditch, Head of Investor Relations
+ 1 (416) 989-8734
investorrelations@northlandpower.com

Victor Gravili, Vice President of Corporate Affairs
+1 (416) 895-5433
communications@northlandpower.com

FORWARD LOOKING INFORMATION

This news release contains statements that constitute forward-looking information within the meaning of applicable securities laws (“forward-looking statements”) that are provided for the purpose of presenting information about management’s current expectations and plans. Readers are cautioned that such statements may not be appropriate for other purposes. Northland’s actual results could differ materially from those expressed in, or implied by, these forward-looking statements and, accordingly, the events anticipated by the forward-looking statements may or may not transpire or occur. Forward-looking statements include statements that are predictive in nature, depend upon or refer to future events or conditions, or include words such as “anticipates”, “expects,” “believes,” or negative versions thereof and other similar expressions or future or conditional verbs such as “may,” “will,” “should,” “would” and “could.” These statements may include, without limitation, statements regarding Northland’s expectations for the operating capacity of the Project and the size of Northland’s development pipeline, all of which may differ from the expectations stated herein. These statements are based upon certain material factors or assumptions that were applied in developing the forward-looking statements, including the provisions of contracts to which Northland or a subsidiary is a party, as well as other factors, estimates, and assumptions that are believed to be appropriate in the circumstances. Although these forward-looking statements are based upon management’s current reasonable expectations and assumptions, they are subject to numerous risks and uncertainties. Some of the factors include, but are not limited to, those described in the “Risks Factors” section of Northland’s Management’s Discussion and Analysis and Annual Information Form for the year ended December 31, 2025, which can be found at www.sedarplus.ca under Northland’s profile and on Northland’s website at northlandpower.com. Northland has attempted to identify important factors that could cause actual results to materially differ from current expectations, however, there may be other factors that cause actual results to differ materially from such expectations. Northland’s actual results could differ materially from those expressed in, or implied by, these forward-looking statements and, accordingly, no assurances can be given that any of the events anticipated by the forward-looking statements will transpire or occur, and Northland cautions you not to place undue reliance upon any such forward-looking statements.

The forward-looking statements contained in this release are, unless otherwise indicated, stated as of the date hereof and are based on assumptions that were considered reasonable as of the date hereof. Other than as specifically required by law, Northland undertakes no obligation to update any forward-looking statements to reflect events or circumstances after such date or to reflect the occurrence of unanticipated events, whether as a result of new information, future events or results, or otherwise.

VANCOUVER, British Columbia, Sept. 29, 2026 (GLOBE NEWSWIRE) — GoldHaven Resources Corp. (CSE: GOH) (OTCQB: GHVNF) (FSE: 4QS) (“GoldHaven” or the “Company”) is pleased to highlight that, while current drilling is focused on the Kuhn target, GoldHaven’s amended Mines Act Permit provides the Company with significant flexibility to systematically evaluate multiple high-priority exploration areas across the broader Magno Project.

The permit authorizes up to 93 ground-based drill pads across seven work zones, four staging areas, modifications to up to 45 kilometres of existing access, and additional exploration trail construction within the approved work program.

Highlights

• 93 permitted drill pads across seven work zones provide flexibility to test multiple targets across Magno.
• 2026 drilling is underway at Kuhn, targeting tungsten-bearing skarn mineralization.
• D Zone / Magno hosts high-grade historical silver-lead-zinc mineralization, including 7.6 metres grading 240 g/t Ag, 4.73% Pb and 4.74% Zn.
• The broader project hosts tungsten, silver, lead, zinc, copper and critical-mineral potential within a large intrusion-related system.
• Permitted targets extend beyond Kuhn to include Dead Goat, D Zone / Magno, Lamb Mountain, Contact and Lang Creek.

Rob Birmingham, President and CEO of GoldHaven, commented:

“Kuhn remains a key focus of our 2026 drill program, but it is also one part of a much broader mineralized system. With 93 permitted drill pads across seven work zones, we have the flexibility to evaluate multiple targets across a large project footprint. As drilling advances at Kuhn, our technical team is also evaluating D Zone and other priority areas across Magno to determine how best to allocate the remainder of our 2026 drill program.”

A Multi-Target Exploration Opportunity

GoldHaven’s permitted exploration footprint encompasses several areas of geological interest across Magno and provides the Company with multiple opportunities to evaluate different mineralization styles within the broader property-scale system.

Figure 1: Magno Project – 93 Permitted Drill Pads Across Seven Multi-Target Work Zones

Kuhn and Dead Goat

The current focus of GoldHaven’s 2026 drill campaign and the Company’s principal tungsten-skarn target area. Historical and modern work has identified tungsten-bearing skarn developed within favourable carbonate stratigraphy adjacent to intrusive rocks.

At Kuhn, two principal skarn horizons, the Lower and Upper 3a, have been traced at surface for approximately 640 metres and 206 metres, respectively, with geological mapping indicating potential strike extensions of up to approximately 2 kilometres. The skarns are characterized by diopside-garnet assemblages with scheelite, pyrrhotite and locally molybdenum and base-metal mineralization. Similar tungsten-bearing skarn occurs at Dead Goat, where mineralization has been mapped over a surface expression of up to approximately 200 metres.

D Zone / Magno Area

A high-priority polymetallic target area characterized by silver-lead-zinc mineralization hosted within carbonate rocks of the Lower Cambrian Atan Group. Historical and recent work has identified structurally controlled skarn and carbonate-replacement-style mineralization occurring as bedding-parallel “manto” bodies and crosscutting “chimney”-style zones.

Mineralization includes galena, sphalerite, magnetite and locally massive sulphides, providing the Company with a distinctly different target style from the tungsten-focused Kuhn area.

Historical drilling at the D Zone included a reported interval of 7.6 metres grading 240 g/t silver, 4.73% lead and 4.74% zinc. This historical result predates NI 43-101 and has not been independently verified by a Qualified Person for GoldHaven.

More recent exploration has confirmed strong silver-lead-zinc mineralization across the broader Magno and D Zone trend, including silver values exceeding 2,000 ppm in structurally controlled skarn mineralization.

Lamb Mountain

A permitted exploration area located north of the central Magno target area and positioned within the broader intrusive and mineralized system being evaluated by GoldHaven. Property-wide geochemical work has identified elevated high-temperature pathfinder elements in the broader area south of Lamb Mountain, including anomalous bismuth, which forms part of the dataset being used to trace structural fluid pathways and vector toward potential intrusive sources.

Contact Area

A centrally located permitted exploration area positioned within the broader Magno intrusive and carbonate-contact environment. The Magno Project covers the contact between Cretaceous-aged intrusive rocks and carbonate-rich sedimentary rocks of the Cassiar Terrane, a geological relationship interpreted to control much of the property’s skarn and carbonate-replacement mineralization. The Contact Area provides an opportunity to evaluate additional sections of this favourable intrusive-carbonate interface.

Lang Creek

A permitted exploration area in the southern portion of the Magno Project, located near Highway 37 and forming part of GoldHaven’s broader strategy to evaluate mineralization across the entire property. Its location provides an additional opportunity to evaluate prospective geology along the southern extent of the Magno system while benefiting from nearby road access. The Company intends to integrate geological mapping, historical information, geochemistry and geophysical data when prioritizing future drilling across Lang Creek and other permitted target areas.

The approved work program provides access to the Kuhn and Dead Goat, Granite D / Magno, Lamb Mountain, Contact and Lang Creek areas, allowing GoldHaven to progressively evaluate multiple target styles across the broader Magno mineral system.

Property-Scale Geological Framework

GoldHaven’s recent work has helped define a broader property-scale mineral zonation model at Magno. Integrated geological mapping, sampling and geochemical analysis indicate an intrusion-related system with copper-gold-silver mineralization in more proximal settings, silver-lead-zinc mineralization in intermediate zones, and tungsten-skarn and additional replacement-style mineralization elsewhere across the property.

Recent work has identified copper values of up to 6,660 ppm at Magno, elevated copper within intrusive rocks, tungsten mineralization at Kuhn and Dead Goat, and strong bismuth and tellurium anomalies interpreted as high-temperature pathfinder elements and indicators of structural fluid pathways. Elevated indium associated with zinc mineralization further reinforces the project’s broader critical-mineral potential.

Building Beyond Kuhn

GoldHaven is currently evaluating the sequencing and prioritization of additional targets as drilling progresses at Kuhn. Geological observations, historical exploration data, surface geochemistry and geophysical information are being integrated to determine where additional drill metres can generate the greatest exploration value.

The Company expects to provide further updates regarding target prioritization and drilling plans as the 2026 program progresses.

Historical Results and Estimates

Certain historical exploration results and estimates referenced in this news release were completed prior to the implementation of NI 43-101 and have not been independently verified by a Qualified Person for GoldHaven. These historical results should not be relied upon as current mineral resources or reserves. The Company considers the historical information relevant as a guide to ongoing exploration and intends to continue evaluating and verifying these areas through modern exploration methods.

Qualified Person

The technical and scientific information contained in this news release has been reviewed and approved by Raymond Wladichuk, P.Geo., who is a non-independent Qualified Person as defined under NI 43-101 and a consultant of the Company.

About GoldHaven Resources Corp.

GoldHaven Resources Corp. is a Canadian junior exploration company focused on advancing highly prospective mineral projects in North and South America. The Company’s flagship asset is the district-scale Magno Project in the Cassiar District of northern British Columbia. GoldHaven also owns the Three Guardsmen copper-gold project in British Columbia and the Copeçal Gold Project in Mato Grosso, Brazil. In addition, the Company holds a portfolio of critical-mineral projects in Brazil.

On Behalf of the Board of Directors

Rob Birmingham, Chief Executive Officer

For further information, please contact:
Rob Birmingham, CEO
www.GoldHavenresources.com
info@goldhavenresources.com
Office Direct: (604) 629-8254

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE – Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statements Regarding Forward-Looking Information

This news release contains forward-looking statements and forward-looking information (collectively, “forward-looking statements”) within the meaning of applicable Canadian and U.S. securities legislation, including the United States Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, included herein including, without limitation, those listed below under the heading “Forward-Looking Statements in This News Release” are forward-looking statements. Although the Company believes that such statements are reasonable, it can give no assurance that such expectations will prove to be correct. Forward-looking statements are typically identified by words such as: “believes”, “will”, “expects”, “anticipates”, “intends”, “estimates”, “plans”, “may”, “should”, “potential”, “scheduled”, or variations of such words and phrases and similar expressions, which, by their nature, refer to future events or results that may, could, would, might or will occur or be taken or achieved. In making the forward-looking statements in this news release, the Company has applied several material assumptions, including without limitation, that there will be investor interest in future financings, market fundamentals will result in sustained demand and prices for precious metals, base metals and critical minerals, the receipt of any necessary permits, licenses and regulatory approvals in connection with the future exploration and development of any future projects in a timely manner, the availability of financing on suitable terms for exploration and development of future projects and the Company’s ability to comply with environmental, health and safety laws.

The Company cautions investors that any forward-looking statements by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward-looking statements as a result of various factors, including operating and technical difficulties in connection with mineral exploration and development activities, actual results of exploration activities, the estimation or realization of mineral reserves and mineral resources, the inability of the Company to obtain the necessary financing required to conduct its business and affairs, as currently contemplated, the inability of the Company to enter into definitive agreements in respect of possible Letters of Intent, the timing and amount of estimated future production, the costs of production, capital expenditures, the costs and timing of the development of new deposits, requirements for additional capital, future prices of precious metals, changes in general economic conditions, changes in the financial markets and in the demand and market price for commodities, lack of investor interest in future financings, accidents, labour disputes and other risks of the mining industry, delays in obtaining governmental approvals, permits or financing or in the completion of development or construction activities, changes in laws, regulations and policies affecting mining operations, title disputes, the inability of the Company to obtain any necessary permits, consents, approvals or authorizations, including by the Exchange, the timing and possible outcome of any pending litigation, environmental issues and liabilities, and risks related to joint venture operations, and other risks and uncertainties disclosed in the Company’s latest interim Management’s Discussion and Analysis as filed with certain securities commissions in Canada. All of the Company’s Canadian public disclosure filings may be accessed via www.sedarplus.ca and readers are urged to review these materials.

Readers are cautioned not to place undue reliance on forward-looking statements. The Company undertakes no obligation to update any of the forward-looking statements in this news release or incorporated by reference herein, except as otherwise required by law.

Forward-Looking Statements in This News Release

The following statements in this news release constitute forward-looking information:

• The amended Mines Act Permit providing flexibility to systematically evaluate multiple high-priority exploration areas across the Magno Project;
• The 2026 drill program at Kuhn testing tungsten-bearing skarn mineralization;
• Potential strike extensions of the Lower and Upper 3a skarn horizons at Kuhn of up to approximately 2 kilometres;
• Evaluation of D Zone and other priority areas to determine allocation of the remainder of the 2026 drill program;
• The Magno Project hosting tungsten, silver, lead, zinc, copper and critical-mineral potential within a large intrusion-related system;
• Progressive evaluation of multiple target styles across the Kuhn and Dead Goat, D Zone / Magno, Lamb Mountain, Contact and Lang Creek areas;
• Integration of geological mapping, historical data, geochemistry and geophysics to prioritize future drilling at Lang Creek and other permitted targets;
• Sequencing and prioritization of additional targets as drilling progresses at Kuhn, and additional drill metres generating the greatest exploration value;
• Elevated indium associated with zinc mineralization reinforcing the project’s broader critical-mineral potential;
• Further updates regarding target prioritization and drilling plans as the 2026 program progresses; and
• Continued evaluation and verification of historical results through modern exploration methods.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/ffa73a54-872d-45e1-bfff-c1d4ef531a1c

Not for distribution to U.S. newswire services or dissemination in the United States.

TORONTO, Sept. 29, 2026 (GLOBE NEWSWIRE) — Flagship Communities Real Estate Investment Trust (TSX:MHC.U) (TSX:MHC.UN) (“Flagship” or the “REIT”) today announced it has expanded its presence in its home state of Kentucky, with the acquisition of a 125-lot manufactured housing community (“MHC”) for total consideration of approximately US$2.0 million (the “Acquisition”).

“This Acquisition is another reflection of our ability to execute on our growth strategy that has been a cornerstone of our success for over 30 years,” said Kurt Keeney, President and Chief Executive Officer. “We expect the Acquisition to generate economies of scale and operational synergies, and it is consistent with our strategy of acquiring established communities with occupancy upside and the opportunity to add value through new amenities.”

The MHC community, which is 54% occupied, is located in Frankfort, Kentucky, where affordable housing is in high demand. Planned improvements include a new clubhouse and office, a basketball court and a playground. Frankfort serves as the capital and the base for the Commonwealth of Kentucky and is home to major employers including the largest number of public administration jobs in the Commonwealth.

“This Acquisition is an exciting opportunity for us to expand in Central Kentucky, a key market for us, where we have four nearby properties,” said Nathan Smith, Chief Investment Officer. “Purchasing properties near communities where we operate allows us to continue to improve efficiencies by managing nearby properties together. The Acquisition is also strategically located near two major Interstates, I-64 and I-75, which provide access to major employers for our residents.”

About Flagship Communities Real Estate Investment Trust

Flagship Communities Real Estate Investment Trust is a leading operator of affordable residential MHCs primarily serving working families seeking affordable home ownership. The REIT owns and operates exceptional residential living experiences and investment opportunities in family-oriented communities in Kentucky, Indiana, Ohio, Tennessee, Arkansas, Missouri, West Virginia, and Illinois. To learn more about Flagship, visit www.flagshipcommunities.com.

Forward-Looking Statements

This news release contains statements that include forward-looking information (within the meaning of applicable Canadian securities laws). Forward-looking statements are identified by words such as “believe”, “anticipate”, “project”, “expect”, “intend”, “plan”, “will”, “may”, “can”, “could”, “would”, “must”, “estimate”, “target”, “objective”, and other similar expressions, or negative versions thereof, and include statements herein concerning: Plans for the acquired MHC and the expected economies of scale and operational synergies from the Acquisition.

These statements are based on the REIT’s expectations, estimates, forecasts, and projections, as well as assumptions that are inherently subject to significant business, economic and competitive uncertainties and contingencies that could cause actual results to differ materially from those that are disclosed in such forward-looking statements. While considered reasonable by management of the REIT as at the date of this news release, any of these expectations, estimates, forecasts, projections, or assumptions could prove to be inaccurate, and as a result, the forward-looking statements based on those expectations, estimates, forecasts, projections, or assumptions could be incorrect. Material factors and assumptions used by management of the REIT to develop the forward-looking information in this news release include, but are not limited to, the REIT’s current expectations about: vacancy and rental growth rates in MHCs and the continued receipt of rental payments in line with historical collections; demographic trends in areas where the MHCs are located; the applicability of any government regulation concerning MHCs and other residential accommodations; the availability of debt financing and future interest rates; increasing expenditures and fees, in connection with the ownership of MHCs, driven by inflation or tariffs; tax laws; and general economic conditions.

When relying on forward-looking statements to make decisions, the REIT cautions readers not to place undue reliance on these statements, as they are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. A number of factors could cause actual results to differ materially from the results discussed in the forward-looking statements, including, but not limited to, the factors discussed or referenced under the heading “Risks and Uncertainties” in the REIT’s most recent annual and subsequent interim Management’s Discussion & Analysis or otherwise disclosed in the Annual Information Form. There can be no assurance that forward-looking statements will prove to be accurate as actual outcomes and results may differ materially from those expressed in these forward-looking statements. Further, certain forward-looking statements included in this news release may be considered as “financial outlook” for purposes of applicable Canadian securities laws, and as such, the financial outlook may not be appropriate for purposes other than to understand management’s current expectations and plans relating to the future, as disclosed in this news release. Forward-looking statements are made as of the date of this news release and, except as expressly required by applicable law, the REIT assumes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

An explanation (which is incorporated by reference herein) of the composition of AFFO can be found under the heading “Non-IFRS Financial Measures” in the REIT’s most recent Management’s Discussion & Analysis (which can be accessed under the REIT’s SEDAR+ profile at www.sedarplus.com).

For further information, please contact:

Eddie Carlisle, Chief Financial Officer
Flagship Communities Real Estate Investment Trust
Tel: +1 (859) 568-3390

TORONTO, Sept. 29, 2026 (GLOBE NEWSWIRE) — Xanadu Quantum Technologies Limited (“Xanadu”; NASDAQ/TSX: XNDU), a leading photonic quantum computing company, and Bluefors, the industry-leader in cryogenic solutions, announced today a strategic partnership to develop a novel, high-performance cryogenic prototype for utility-scale quantum computing (USQC). This work aims to realize a shared vision of scalable modular cryogenic infrastructure for USQC.

This partnership represents a key milestone for Xanadu and Bluefors’ joint development efforts. The USD $ multi-million collaboration will leverage Bluefors’ cutting-edge cryogenic solutions and aims to establish a foundational blueprint not only for Xanadu’s planned USQC data centre, but for all future USQC data centres.

“Until recently, the industry assumed that USQC would require massive, industrial-scale cryoplants,” said Dr. Christian Weedbrook, Founder and Chief Executive Officer of Xanadu. “Our collaboration with Bluefors has yielded a concept that integrates their most advanced technology into a compact module. This approach is expected to remove the need for traditional cryoplants, greatly improving the scalability and economics of future quantum data centres.”

Looking ahead, Xanadu and Bluefors plan to utilize insights from this development to engineer a mass-manufacturable cryogenic module tailored specifically for single-photon detectors and USQC in a data centre environment.

“Bluefors and Xanadu share a vision of making utility-scale quantum computing achievable,” said Kim Povlsen, Chief Executive Officer of Bluefors. “We are delivering a high-powered, modular and cryo-tested solution that combines cooling and quantum infrastructure designed to grow alongside our customers’ technology roadmaps. By meeting the cooling demands that infrastructure investments need to scale, we help customers optimize time-to-value and build a strong foundation to accelerate the next generation of fault-tolerant quantum computers.”

About Xanadu

Founded in 2016, Xanadu is a Canadian photonic quantum computing company with the mission to build quantum computers that are useful and available to people everywhere. Xanadu is building fault-tolerant quantum computers using light, with systems designed to compute at room temperature. Xanadu develops both hardware and software, including PennyLane, its open-source quantum computing platform. Xanadu is the first pure-play photonic quantum computing company to list on public markets (Nasdaq/TSX: XNDU) and is recognized globally for its breakthroughs in scalable quantum technologies. Visit xanadu.ai or follow on X @XanaduAI.

Contacts

Press Contact:
press@xanadu.ai
Investor Relations:
investors@xanadu.ai

About Bluefors

Bluefors envisions a world where everyone has access to the power of quantum. As the world-leading quantum infrastructure company providing the fundamental quantum computing infrastructure of cryogenic systems, wiring, and ongoing system support, we are the trusted partner for the world’s most advanced companies that build and aim to harness the future of quantum. With a revenue of over EUR 210 million, over 700 employees, and more than 1,800 systems delivered and operating around the world, we are helping to accelerate the imminent arrival of quantum datacenters and the practical application of scalable quantum computing for companies across the widest range of modalities.

Forward-Looking Statements

This communication includes “forward-looking statements” within the meaning of the U.S. federal securities laws and “forward-looking information” within the meaning of applicable Canadian securities laws (collectively, “forward-looking statements”). Forward-looking statements may be identified by the use of words such as “estimate,” “plan,” “project,” “forecast,” “intend,” “will,” “expect,” “anticipate,” “believe,” “seek,” “target,” “continue,” “could,” “may,” “might,” “possible,” “potential,” “predict” or similar expressions that predict or indicate future events or trends or that are not statements of historical matters. We have based these forward-looking statements on current expectations and projections about future events. These statements include: statements regarding the strategic multi-million dollar partnership with Bluefors and the ability to successfully collaborate; the ability to develop a novel, high-performance cryogenic prototype and realize a scalable modular cryogenic infrastructure for utility-scale quantum computing (USQC); the ability of the collaboration to establish a foundational blueprint for Xanadu’s planned USQC data centre and future quantum data centres; the expected performance, cooling capabilities, integration, and modularity of the cryogenic solution, including its ability to accommodate high-density optical fiber and flex-cabling for Superconducting Nanowire Single-Photon Detectors (SNSPDs) near 2 Kelvin; the potential to eliminate the need for traditional industrial-scale cryoplants and improve the scalability and economics of future quantum data centres; plans to utilize development insights to engineer a mass-manufacturable cryogenic module; the expected acceleration of fault-tolerant quantum computers; and Xanadu’s mission to build quantum computers that are useful and available to people everywhere.

These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions, many of which are beyond the control of Xanadu. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions that may cause the actual results of Xanadu, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such statements. Such risks and uncertainties include: **the risk that the strategic partnership with Bluefors may not achieve its intended technical or economic benefits; technical and engineering challenges in designing, prototyping, testing, and mass-manufacturing modular cryogenic infrastructure operating near 2 Kelvin; risks associated with reliance on Bluefors as a key infrastructure partner and potential supply chain or manufacturing delays; the risk that the prototype may not successfully accommodate required SNSPD optical fiber and flex-cabling at scale or eliminate the need for industrial-scale cryoplants; that Xanadu is pursuing an emerging technology, faces significant technical challenges and may not achieve commercialization or market acceptance; Xanadu’s historical net losses and limited operating history; that there is substantial doubt about Xanadu’s ability to continue as a going concern; Xanadu’s expectations regarding future financial performance, capital requirements and unit economics; Xanadu’s use and reporting of business and operational metrics; Xanadu’s competitive landscape; Xanadu’s dependence on members of its senior management and its ability to attract and retain qualified personnel; the potential need for additional future financing; Xanadu’s ability to manage growth and expand its operations; potential future acquisitions or investments in companies, products, services or technologies; Xanadu’s reliance on strategic partners and other third parties; Xanadu’s concentration of revenue in contracts with government or state-funded entities; Xanadu’s ability to maintain, protect and defend its intellectual property rights; risks associated with privacy, data protection or cybersecurity incidents and related regulations; the use, rate of adoption, and regulation of artificial intelligence and machine learning; uncertainty or changes with respect to laws and regulations; uncertainty or changes with respect to taxes, trade conditions and the macroeconomic environment; material weaknesses in Xanadu’s internal control over financial reporting and its ability to maintain internal control over financial reporting and operate as a public company; the outcome of any legal proceedings or government investigations that may be commenced against Xanadu; Xanadu’s ability to issue equity or equity-linked securities in the future; and other factors described in Xanadu’s filings with the SEC (www.sec.gov) and the Canadian Securities Administrators (www.sedarplus.com). These forward-looking statements are based on certain assumptions, including that none of the risks identified above materialize; that there are no unforeseen changes to economic and market conditions, and that no significant events occur outside the ordinary course of business. Additional information concerning these and other factors that may impact such forward-looking statements can be found in filings and potential filings by Xanadu with the SEC and the Canadian Securities Administrators, including under the heading “Risk Factors.” If any of these risks materialize or assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. In addition, these statements reflect the expectations, plans and forecasts of Xanadu’s management as of the date of this communication; subsequent events and developments may cause their assessments to change. While Xanadu may elect to update these forward-looking statements at some point in the future, they specifically disclaim any obligation to do so, unless required by applicable securities laws. Accordingly, undue reliance should not be placed upon these statements.

In addition, statements that “we believe” and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this communication, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements.

Martela Corporation, stock exchange release on 29 September 2026 at 13.45 (EEST)

The Extraordinary General Meeting of Martela Corporation was held today on 29 September 2026. The General Meeting approved the Company’s Board of Directors’ proposals to combine the share series and to authorise the Board of Directors to decide on a directed share issue against consideration.

Combination of share series and related amendment of the Articles of Association and directed share issue without consideration

The General Meeting resolved to approve the Board of Directors’ proposal on the combination of the share series, the related amendment to the Articles of Association, and the directed share issue without consideration, following a vote. Approximately 75.9 per cent of all shares represented at the General Meeting and approximately 95.4 per cent of the votes carried by them supported the Board of Directors’ proposal. In terms of share series, approximately 69.1 per cent of the series A shares represented at the General Meeting and the votes carried by them, and 100 per cent of the series K shares represented at the General Meeting and the votes carried by them, supported the proposal. Approximately 24 per cent of the shares represented at the General Meeting and approximately 4.6 per cent of the votes carried by them opposed the Board of Directors’ proposal. In terms of share series, approximately 30.9 per cent of the series A shares represented at the General Meeting and the votes carried by them opposed the proposal. The General Meeting therefore approved the proposal by the qualified majority required per share series under the Finnish Limited Liability Companies Act (624/2006, as amended) (the “Companies Act”). The proposal in its entirety is included in the notice convening the General Meeting published on 8 September 2026, but its main points are as follows:

Combination of share series

The Company’s share series will be combined so that, following the combination, all shares in the Company belong to the same share series and carry equal rights in the Company, including one (1) vote at a General Meeting. In connection with the combination of the share series, the existing series K shares, which have not been subject to trading on the regulated market, are converted to shares whose rights correspond to those of existing series A shares, i.e. shares of the sole series following the combination of share series. The conversion is done on a 1:1 basis, which means that one (1) series K share is converted into one (1) share of the Company’s sole series of shares following the combination of share series, corresponding to the existing series A shares. The Company intends to apply for the converted shares to be admitted to trading on the regulated market.

Amendment of the Articles of Association

In order to implement the combination of the share series, the General Meeting resolved to amend the Company’s Articles of Association by removing the provisions relating to different share series. The resolved amendments are as follows:

1. Article 3 of the Articles of Association, “Osakesarjat ja niiden äänioikeudet” (Share series and the attached voting rights), is deleted.
2. Article 5 of the Articles of Association, “Osakkeiden lunastaminen” (Redemption of shares), is deleted.
3. The numbering of Articles 3–14 of the Articles of Association is amended so that the numbering of the articles remains consecutive following the deletions referred to in paragraphs 1 and 2 above.

The combination of the share series and the amendment of the Articles of Association are estimated to be registered in the Trade Register on approximately 12 October 2026.

Directed share issue without consideration

In connection with the combination of share series, the General Meeting resolved on a directed share issue without consideration to the holders of series K shares, whereby, in deviation from the shareholders’ pre-emptive subscription right, shareholders receive one (1) new share of the Company’s sole series of shares following the combination of share series, corresponding to the existing series A shares, for every four (4) series K shares held in the same book-entry account. The purpose of the share issue is to compensate the holders of series K shares for the loss of voting rights attached to series K shares resulting from the combination of the share series. The maximum number of shares to be issued is 151,200. All shareholders who hold series K shares in the book-entry system on 12 October 2026, the record date of the share issue, are entitled to receive new shares of the Company’s sole series of shares following the combination of share series, corresponding to the existing series A shares.

The directed share issue without consideration does not require any actions by the shareholders. The shares issued in connection with the directed share issue without consideration are registered with the Trade Register concurrently with the amendments to the Articles of Association, or as soon as possible thereafter.

Amendments to authorisations

Following the combination of share series, the resolutions of the Company’s Annual General Meeting of 8 April 2026 concerning (i) the authorisation of the Board of Directors to decide on the repurchase and/or acceptance of pledge of the Company’s own shares, and (ii) the authorisation of the Board of Directors to decide on share issues as well as on the issuance of option rights and other special rights entitling to shares, shall henceforth apply to the shares of the Company’s sole share series.

Authorising the Board of Directors to resolve on a directed share issue against consideration

The General Meeting resolved to approve the Board of Directors’ proposal to authorise the Board of Directors to decide on a directed share issue against consideration, based on the results of the advance voting. Approximately 74.4 per cent of the shares represented at the General Meeting and approximately 95 per cent of the votes carried by them had supported the Board of Directors’ proposal in the advance voting. Approximately 1.1 per cent of the shares represented at the General Meeting and approximately 0.2 per cent of the votes carried by them had opposed the Board of Directors’ proposal in the advance voting. The General Meeting therefore approved the proposal by the qualified majority required under the Companies Act. The proposal in its entirety is included in the notice convening the General Meeting published on 8 September 2026, but its main points are as follows:

Under the authorisation, a maximum of 17,777,777 new series A shares or shares of the Company’s sole series of shares following the combination of share series, corresponding to the existing series A shares, may be issued to a group of domestic investors determined by the Board of Directors. The share issue will be carried out in deviation from the shareholders’ pre-emptive subscription right under Chapter 9, Section 3 of the Companies Act i.e. as a directed share issue. The share subscription price is EUR 0.45. The Board of Directors was authorised to resolve on the subscription period and payment period of the shares as well as on any other terms and conditions of the share issue and to attend to the practical measures relating to the share issue.

According to the assessment of the Company’s Board of Directors, there is a weighty financial reason referred to in Chapter 9, Section 4(1) of the Companies Act for deviating from the shareholders’ pre-emptive right.

The authorisation is valid until 31 December 2026. The authorisation does not revoke any previous unused authorisations relating to the issuance of shares or the issuance of option rights or other special rights entitling to shares.

The minutes of the Extraordinary General Meeting

The minutes of the Extraordinary General Meeting will be available on the Company’s website at https://www.martela.com/about-us/about-martela/investors/corporate-governance/general-meeting by 13 October 2026, at the latest.

MARTELA CORPORATION

For further information:

CEO, Panu Ala-Nikkola
tel +358 50 502 4728

CFO, Henri Berg
tel +358 40 836 5464

Chairman of the Board, Tapio Pajuharju
tel +358 50 5774 200

Martela is a Nordic leader specialising in user-centric working and learning environments. With over 80 years of experience, we create the best places to work and offer our customers the Martela Lifecycle solutions which combine furniture and related services into a seamless whole.

Distribution:
Nasdaq Helsinki
Main media
www.martela.com

MONACO, Sept. 29, 2026 (GLOBE NEWSWIRE) — Scorpio Tankers Inc. (NYSE: STNG) (“Scorpio Tankers,” or the “Company”) announced today that it has entered into agreements to sell three product tankers and purchase four newbuilding vessels.

Vessel Sales

The Company has entered into agreements to sell three product tankers comprising the 2014 built scrubber-fitted MR product tanker, STI Dama, for $37.5 million, the 2014 built scrubber-fitted LR2 product tanker, STI Elysees, for $70.0 million, and the 2015 built scrubber-fitted LR2 product tanker, STI Veneto, for $73.0 million. The sales are expected to close before the end of 2026.

Newbuilding Vessel Purchases

The Company has entered into agreements to purchase four newbuilding vessels comprising two scrubber-fitted LR2 product tankers and two scrubber-fitted VLCCs. The LR2s are expected to be constructed at Jiangsu Hantong Ship Heavy Industry Co., Ltd. in China for $72.8 million per vessel with deliveries expected in October and November 2029. The VLCCs are expected to be constructed at Hengli Shipbuilding (Dalian) Co., Ltd. for $135.0 million per vessel with deliveries expected in September and October 2028.

About Scorpio Tankers Inc.

Scorpio Tankers Inc. is a provider of marine transportation of petroleum products worldwide. Scorpio Tankers Inc. currently owns 74 product tankers (25 LR2 tankers, 35 MR tankers and 14 Handymax tankers) with an average age of 10.2 years. The Company has reached agreements or letters of intent for five MR newbuildings that are currently under construction with deliveries expected in 2027 and 2030, eight LR2 newbuildings with deliveries expected in 2027 and 2029 and four VLCC newbuildings with deliveries expected in 2028. Additional information about the Company is available at the Company’s website www.scorpiotankers.com. Information on the Company’s website does not constitute a part of and is not incorporated by reference into this press release.

Forward-Looking Statements

Matters discussed in this press release may constitute forward‐looking statements. The Private Securities Litigation Reform Act of 1995 provides safe harbor protections for forward‐looking statements in order to encourage companies to provide prospective information about their business. Forward‐looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements, which are other than statements of historical facts. The Company desires to take advantage of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and is including this cautionary statement in connection with this safe harbor legislation. The words “believe,” “expect,” “anticipate,” “estimate,” “intend,” “plan,” “target,” “project,” “likely,” “may,” “will,” “would,” “could” and similar expressions identify forward‐looking statements.

The forward‐looking statements in this press release are based upon various assumptions, many of which are based, in turn, upon further assumptions, including without limitation, management’s examination of historical operating trends, data contained in the Company’s records and other data available from third parties. Although management believes that these assumptions were reasonable when made, because these assumptions are inherently subject to significant uncertainties and contingencies which are difficult or impossible to predict and are beyond the Company’s control, there can be no assurance that the Company will achieve or accomplish these expectations, beliefs or projections. The Company undertakes no obligation, and specifically declines any obligation, except as required by law, to publicly update or revise any forward‐looking statements, whether as a result of new information, future events or otherwise.

In addition to these important factors, other important factors that, in the Company’s view, could cause actual results to differ materially from those discussed in the forward‐looking statements include unforeseen liabilities, future capital expenditures, revenues, expenses, earnings, synergies, economic performance, indebtedness, financial condition, losses, future prospects, expansion and growth of the Company’s operations, risks relating to the integration of assets or operations of entities that it has or may in the future acquire and the possibility that the anticipated synergies and other benefits of such acquisitions may not be realized within expected timeframes or at all, the failure of counterparties to fully perform their contracts with the Company, the strength of world economies and currencies, general market conditions, including fluctuations in charter rates and vessel values, changes in demand for tanker vessel capacity, changes in the Company’s operating expenses, including bunker prices, drydocking and insurance costs, the market for the Company’s vessels, availability of financing and refinancing, charter counterparty performance, ability to obtain financing and comply with covenants in such financing arrangements, changes in governmental rules and regulations or actions taken by regulatory authorities, the impact of the current and future sanctions that may impact the transportation of petroleum products, the ongoing military conflict in Iran which has had a significant direct and indirect impact on the trade of crude oil and refined petroleum products, potential disruption of shipping routes due to accidents or political events, potential liability from pending or future litigation, general domestic and international political conditions, which have and may continue to disrupt certain global shipping routes, vessel breakdowns and instances of off‐hires, and other factors. Please see the Company’s filings with the SEC for a more complete discussion of certain of these and other risks and uncertainties.

Contact Information

Scorpio Tankers Inc.
James Doyle – Head of Corporate Development & Investor Relations
Tel: +1 203-900-0559
Email: investor.relations@scorpiotankers.com

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Rule 8.3 of the Takeover Code (the “Code”)

1.        KEY INFORMATION

(a)   Full name of discloser:	Man Group PLC
(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):         The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:         Use a separate form for each offeror/offeree	Gamma Communications plc
(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
(e)   Date position held/dealing undertaken:         For an opening position disclosure, state the latest practicable date prior to the disclosure	28/09/2026
(f)   In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?	NO

2.        POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a)      Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:	0.25p ordinary
	Interests		Short positions
	Number	%	Number	%
(1)   Relevant securities owned and/or controlled:
(2)   Cash-settled derivatives:	895,228	1.00
(3)   Stock-settled derivatives (including options) and agreements to purchase/sell:
TOTAL:	895,228	1.00

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b)      Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3.        DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a)        Purchases and sales

Class of relevant security

Purchase/sale

Number of securities

Price per unit

(b)        Cash-settled derivative transactions

Class of relevant security	Product description e.g. CFD	Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position	Number of reference securities	Price per unit
0.25p ordinary	Equity swap	Increasing a long position	11,872	11.1997 GBP
0.25p ordinary	Equity swap	Increasing a long position	136,417	11.1997 GBP
0.25p ordinary	Equity swap	Increasing a long position	7,063	11.1997 GBP
0.25p ordinary	Equity swap	Increasing a long position	1,667	11.1997 GBP
0.25p ordinary	Equity swap	Increasing a long position	90,407	11.1997 GBP
0.25p ordinary	Equity swap	Increasing a long position	1,863	11.1997 GBP
0.25p ordinary	Equity swap	Increasing a long position	30,930	11.1997 GBP

        
(c)        Stock-settled derivative transactions (including options)

(i)        Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type e.g. American, European etc.

Expiry date

Option money paid/ received per unit

(ii)        Exercise

Class of relevant security

Product description e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

(d)        Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing e.g. subscription, conversion

Details

Price per unit (if applicable)

4.        OTHER INFORMATION

(a)        Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

None

(b)        Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i)   the voting rights of any relevant securities under any option; or (ii)   the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

None

(c)        Attachments

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:	29/09/2026
Contact name:	Molly Childs
Telephone number:	+44 20 7144 3714

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

#FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Rule 8.3 of the Takeover Code (the “Code”)

1.        KEY INFORMATION

(a)   Full name of discloser:	Man Group PLC
(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):         The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:         Use a separate form for each offeror/offeree	Rotork Plc
(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
(e)   Date position held/dealing undertaken:         For an opening position disclosure, state the latest practicable date prior to the disclosure	28/09/2026
(f)   In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?	NO

2.        POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a)      Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:	0.5p ordinary
	Interests		Short positions
	Number	%		Number	%
(1)   Relevant securities owned and/or controlled:
(2)   Cash-settled derivatives:	15,101,007	1.84		11,209	0.00
(3)   Stock-settled derivatives (including options) and agreements to purchase/sell:
TOTAL:	15,101,007	1.84		11,209	0.00

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b)      Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3.        DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a)        Purchases and sales

Class of relevant security

Purchase/sale

Number of securities

Price per unit

(b)        Cash-settled derivative transactions

Class of relevant security	Product description e.g. CFD	Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position	Number of reference securities	Price per unit
0.5p ordinary	Equity swap	Reducing a long position	2,078	4.8584 GBP
0.5p ordinary	Equity swap	Reducing a long position	1,670	4.8583 GBP

(c)        Stock-settled derivative transactions (including options)

(i)        Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type e.g. American, European etc.

Expiry date

Option money paid/ received per unit

(ii)        Exercise

Class of relevant security

Product description e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

(d)        Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing e.g. subscription, conversion

Details

Price per unit (if applicable)

4.        OTHER INFORMATION

(a)        Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

None

(b)        Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i)   the voting rights of any relevant securities under any option; or (ii)   the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

None

(c)        Attachments

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:	29/09/2026
Contact name:	Molly Childs
Telephone number:	+44 20 7144 3714

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.